Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 320

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 1
Chunk 320
---
5, 2023            44,725 (=8,945 ADS)           134,175 (=26,835 ADS)               $12.510      61,700 (=12,340 ADS)       Jun 4, 2033   
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Note:

  (1)      The share options granted between April 28, 2020 and June 5, 2023 were in the form of ADSs and the relevant exercise prices were stated in U. S. dollars per ADS. For purposes of this table, the...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Table of Contents

Long-Term Incentive Compensation

The following table sets forth information regarding performance based LTIP awards granted to our chief executive officer and chief scientific officer, chief financial officer and other executive officers on an aggregate basis in the year ended December 31, 2024.

                                                                       Maximum                               
                                                                       Aggregate                             
                                                                       Value of                              
  Name and Principal Position                                          LTIP awards (1)(2)(3)                 
  Weiguo SU, Chief Executive Officer and Chief Scientific Officer      $                          3,348,180  
  CHENG Chig Fung, Johnny, Chief Financial Officer                     $                            759,951  
  Other Executive Officers in the Aggregate                            $                          1,848,800  

Notes:

  (1)      The amounts reflected in the table above represent the maximum aggregate value of all LTIP awards outstanding as of December 31, 2024. The LTIP awards are conditional upon the achievement of an...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (2)      Vesting will occur in 2027, three weeks after the date of completion of the purchase of shares for the award relating to the Financial Year 2026.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (3)      Excluding performance based LTIP awards abovementioned, a non-performance based LTIP award granted to an Executive Officer in an amount of $500,000, for which 79,652 ordinary shares were alloca...  
 ─────────────────────────────────────────